The regulation of gastrin gene transcription was studied in GH4 pituitary cells transfected with constructs comprised of the first exon of the human gastrin gene and various lengths of 5' regulatory sequences ligated upstream of the reporter gene chloramphenicol acetyltransferase. Gastrin reporter gene activity in GH4 cells was equal to the activity of a reporter gene transcribed from the endogenously expressed growth hormone promoter. The effect of a variety of peptides on gastrin gene transcription including epidermal growth factor (normally present in the gastric lumen), gastrinreleasing peptide, vasoactive intestinal peptide, and somatostatin (present in gastric nerves) was assessed. Epidermal growth factor increased the rate of gastrin transcription almost 3-fold, whereas thyrotropin-releasing hormone and vasoactive intestinal peptide increased gastrin transcription 2-and 1.5-fold, respectively. Gastrin-releasing peptide, a peptide that strongly stimulates gastrin release, weakly increased gastrin transcription (1.3-fold). Somatostatin inhibited the increase in gastrin transcription induced by epidermal growth factor, thyrotropin-releasing hormone, and vasoactive intestinal peptide. Constructs containing various lengths of 5' regulatory sequences defmed a response element -40 to -82 base pairs (bp) 5' to the transcription initiation site. This 40-bp sequence contains Spl and AP2 binding sites, which suggests that epidermal growth factor and thyrotropin-releasing hormone stimulate gastrin gene transcription through transcription factors that bind to Spl and/or AP2 motifs.
ABSTRACT
The regulation of gastrin gene transcription was studied in GH4 pituitary cells transfected with constructs comprised of the first exon of the human gastrin gene and various lengths of 5' regulatory sequences ligated upstream of the reporter gene chloramphenicol acetyltransferase. Gastrin reporter gene activity in GH4 cells was equal to the activity of a reporter gene transcribed from the endogenously expressed growth hormone promoter. The effect of a variety of peptides on gastrin gene transcription including epidermal growth factor (normally present in the gastric lumen), gastrinreleasing peptide, vasoactive intestinal peptide, and somatostatin (present in gastric nerves) was assessed. Epidermal growth factor increased the rate of gastrin transcription almost 3-fold, whereas thyrotropin-releasing hormone and vasoactive intestinal peptide increased gastrin transcription 2-and 1.5-fold, respectively. Gastrin-releasing peptide, a peptide that strongly stimulates gastrin release, weakly increased gastrin transcription (1.3-fold). Somatostatin inhibited the increase in gastrin transcription induced by epidermal growth factor, thyrotropin-releasing hormone, and vasoactive intestinal peptide. Constructs containing various lengths of 5' regulatory sequences defmed a response element -40 to -82 base pairs (bp) 5' to the transcription initiation site. This 40-bp sequence contains Spl and AP2 binding sites, which suggests that epidermal growth factor and thyrotropin-releasing hormone stimulate gastrin gene transcription through transcription factors that bind to Spl and/or AP2 motifs.
Gastrin has a dual action in the gastrointestinal tract, one as the major hormone controlling gastric acid secretion and the other as a growth factor controlling mucosal proliferation (1) (2) (3) . Secretion of gastrin from antral G cells is determined by a complex interplay of stimuli in the gastric lumen and in mucosal nerves (4) . A distinguishing feature of endocrine cells in the gastrointestinal tract is that they are regulated by stimuli in the gastrointestinal lumen via receptors on their apical surface. Although the components of gastric contents that regulate antral G cells are poorly characterized, gastric secretions contain one of the highest concentrations of biologically active epidermal growth factor (EGF) in tissue fluids (5, 6) . Therefore, in addition to its role as a mucosal growth factor, EGF may also regulate antral G cells via luminal receptors on the apical surface of the G cell. Specific receptors for EGF have been characterized on the rat enterocyte (7), and EGF has been shown to stimulate growth of the gastric mucosa (8) . EGF also stimulates hormone gene expression, the best studied example being the pituitary hormone prolactin (9) . Therefore, EGF may stimulate gastrin gene expression in addition to its role as a luminal growth factor. Antral G cells are also stimulated by neuropeptides released from antral nerves, such as gastrin-releasing peptide (GRP) (10, 11) and vasoactive intestinal peptide (VIP) (4) . Although studies ofisolated G cells show that GRP stimulates gastrin secretion (12, 13) , the effect of GRP on gastrin gene expression has not been reported. Antral G cells are also inhibited by the paracrine release of somatostatin from adjacent antral D cells (14) , and local release of somatostatin inhibits gastrin gene expression as well as gastrin secretion (15) .
In contrast to the detailed studies on gastrin secretion, the regulation of gastrin gene expression has not been well investigated. The cellular mechanisms controlling gastrin secretion have been analyzed using isolated primary G cells (12, 13) ; however, the limited viability of these cells has precluded their use in studying the regulation of gastrin gene transcription using DNA transfection techniques. Although there are no permanent cell lines derived from antral G cells, permanent cell lines have been derived from other gastrinexpressing neuroendocrine tissues, such as the anterior pituitary (16, 17) and pancreatic islets (18) . The GH4 pituitary cell line is a particularly attractive cell line for analyzing regulation of the gastrin gene because these cells possess functional receptors for EGF (19) , GRP (20) , thyrotropinreleasing hormone (TRH) (21), VIP (22) , and somatostatin (23) , all putative regulators of gastrin secretion from antral G cells. Furthermore, studies on the stimulation of prolactin gene expression by EGF in GH4 cells have identified an EGF response element within the prolactin gene (24) .
The present study shows that the promoter of the gastrin gene was highly active when transfected into GH4 cells, comparable to the activity of the rat growth hormone promoter, which like Rous sarcoma virus promoter-chloramphenicol acetyltransferase (RSVCAT) is not regulated by EGF (24) . Gastrin promoter activity was stimulated almost 3-fold by EGF and to a lesser degree by TRH and VIP. Somatostatin inhibited the increase in gastrin promoter activity induced by EGF, TRH, and VIP. Deletional mapping identified a 40-base pair (bp) sequence immediately upstream of the TATA box that was required for EGF and TRH stimulation. This sequence contains putative binding motifs for Spl (25) and AP2 (26) transcription factors, suggesting that transcription factors binding to these motifs are activated by EGF.
MATERIALS AND METHODS
Gastrin-Chloramphenicol Acetyltransferase (CAT) Constructs. A phage containing about 1300 bp of 5'-flanking genomic DNA of the human gastrin gene was isolated from a Charon 4A human genomic library that was identical to the one described by Ito et al. (27) . An EcoRI-Pst I fragment of this genomic insert, which included 1300 bp of 5'-flanking sequence and the entire first exon (noncoding) was ligated upstream of a promoterless CAT gene in the expression Abbreviations: EGF, epidermal growth factor; GRP, gastrinreleasing peptide; TRH, thyrotropin-releasing hormone; VIP, vasoactive intestinal peptide; CAT, chloramphenicol acetyltransferase; LTR, long terminal repeat; GASCAT, gastrin promoter-CAT; RS-VCAT, Rous sarcoma virus promoter-CAT; GHCAT, growth hormone promoter-CAT.
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Proc. NatL. Acad. Sci. USA 86 (1989) 3037 vector pOCAT (1300 GASCAT) (28) . The growth hormone promoter-CAT plasmid (GHCAT) was a gift from David Moore (Harvard Medical School, Massachusetts General Hospital) (29) .
Cell Culture and Transfections. GH4 cells were cultured in Ham's F-10 medium with 12.5% horse serum, 2.5% fetal calf serum, penicillin at 100 jig/ml and streptomycin (medium) at 100 pug/ml in a humidified atmosphere of 5% C02/95% air. Stable transformants: The 1300 GASCAT plasmid was transfected with the RSVneo plasmid, which expresses the neomycin resistance gene from the Rous sarcoma virus promoter (GASCAT:RSVCAT, 30:1 ratio) as a calcium phosphate coprecipitate (30) . Transfected cells were selected by resistance to the neomycin analogue G418 at 400 gg/ml. Pooled stable transformants were then used in EGF regulation studies. Transient expression assays: Subconfluent GH4 cells were transfected with a mixture containing DEAE-dextran at 400 ,ug/ml, DNA at 5 gg/ml, and 50 mM Tris HCI in F-10 medium without serum for 15 min at 370C followed by glycerol shock for 2 min (31, 32) . EGF and neuropeptides were added the day after transfection and 24 hr before preparing cell extracts.
CAT Assays. Cell extracts were assayed for CAT by the method of Gorman et al. (33) Primer-Extension Analysis. Primer-extension analysis was carried out after the method of Wu et al. (35) . Thirty micrograms of total RNA extracted from GH4 cells transiently transfected with the 1300 GASCAT construct was hybridized to a 32P-labeled oligonucleotide primer (10 ng; 108 cpm/10 ng) complementary to the coding sequence +85 to + 103 of the CAT gene. RESULTS GH4 Cells Express the Gastrin Promoter. GH4 cells were transfected with a GASCAT plasmid containing 1.3 kilobases (kb) of 5'-flanking DNA and the first exon of the human gastrin gene ligated upstream of the reporter gene CAT. Gastrin promoter activity was measured by assaying CAT enzyme activity in extracts of transfected GH4 cells and was compared with the activity of RSVCAT and GHCAT plasmids (Fig. 1A) . In RSVCAT, the CAT gene is transcribed from the Rous sarcoma virus long terminal repeat (LTR) promoter that is highly expressed in many cell types. In GHCAT, the CAT gene is transcribed from the rat growth hormone promoter, which regulates a gene specifically expressed in GH4 cells (29) . In transient expression assays, GASCAT activity was nearly 50% of RSVCAT activity and similar to that of GHCAT activity (Fig. LA) . In contrast, GASCAT activity in fibroblast (3T3) cells was <5% of RSVCAT (Fig. 1A) . Although the endogenous gastrin gene is not expressed in GH4 cells, the gastrin promoter is as active as the growth hormone promoter, indicating that GH4 cells possess specific transcription factors-not present in fibroblasts-that are necessary to activate the gastrin promoter. Primer-extension analysis demonstrated that CAT activity resulted from mRNA that initiates from the authentic gastrin promoter (Fig. 1B) . The expected 215-bp primer-extension product was seen in GH4 cells transfected with a GASCAT plasmid, but not in mock-transfected GH4 cells.
The cis regulatory DNA sequences controlling gastrin promoter activity were identified by measuring the activity of GASCAT plasmids containing sequential deletions of 5'-flanking DNA. GASCAT reporter genes having 600, 194, or 82 bp of 5'-flanking DNA had similar activity to that of the 1300 GASCAT plasmid (Fig. 2) Biochemistry: Godley and Brand retained half of the promoter activity found in the 1300 construct (Fig. 2) . Therefore, the cis regulatory elements necessary for basal gastrin promoter activity in GH4 cells are found close to the TATA box or within the first exon of the gastrin gene.
EGF Stimulates Gastrin Promoter Activity. Gastrin promoter activity increased 3-fold after incubating GH4 cells for 24 hr with 1-100 nM EGF (Fig. 3A) . Although the response of the promoter to EGF was modest, it was comparable to the response observed for the rat prolactin promoter (3-fold) (24) and the tyrosine hydroxylase promoter (3-fold) (36) . The gastrin promoter response to EGF stimulation was equal in magnitude to the increase in endogenous prolactin mRNA seen in these GH4 cells with EGF (data not shown). However, growth hormone mRNA levels in these GH4 cells stably transformed with the GASCAT plasmid were not stimulated by EGF (data not shown), confirming prior observations (19) . EGF increased gastrin promoter activity within 4 hr (Fig. 3B) . The stimulation of gastrin promoter activity by EGF did not plateau even after 72 hr ofincubation, which is similar to EGF stimulation of tyrosine hydroxylase promoter activity (36) . EGF stimulated gastrin promoter activity in GH4 cells with GASCAT stably integrated into chromosomal DNA (Fig. 3 ) and in GH4 cells transiently transfected with the GASCAT plasmid (see Fig. 5 ). Maximal stimulation of the gastrin promoter was seen with 1 nM EGF, which is comparable to the concentration that maximally stimulates the activity of the tyrosine hydroxylase and prolactin promoters (36, 37) .
Neuropeptides Regulate Gastrin Promoter Activity. TRH and VIP modestly increased gastrin promoter activity in GH4 cells by 2-fold and 1.5-fold, respectively (Fig. 4) . However, GRP, the most potent stimulus of gastrin secretion in G cells, stimulated gastrin promoter activity only 1.3-fold. Although the peak effects of GRP and VIP on hormone release occur at <24 hr (12, 22) , the fold change in gastrin promoter activity in response to either peptide was maximal at 24 hr. Isoproterenol (a B-adrenergic agonist) had no effect on gastrin promoter activity and membrane depolarization, whereas 50 mM K+ inhibited promoter activity by almost 50%. The somatostatin analogue, SMS 201-995, effectively antagonized EGF stimulation of gastrin promoter activity without affecting basal gastrin promoter activity (Fig. 5) still 50% of the basal activity of the 1300 GASCAT plasmid (Fig. 2) . Therefore, these results defined a 40-bp sequence between -40 and -82 bp upstream of the gastrin promoter that was required for EGF stimulation of the gastrin promoter. Similarly, TRH responsiveness was also abolished when this 40-bp sequence was removed (Fig. 6B) .
DISCUSSION
Because GH4 cells have receptors for peptide regulators that control G cell secretion, these cells are an attractive model to study the regulation of gastrin gene transcription. Furthermore, the gastrin promoter is as active in GH4 cells as the promoter of specifically expressed genes, such as growth hormone. An explanation for the high GASCAT expression without endogenous gastrin gene expression is the possibility that there are repressor elements further upstream not present in the GASCAT constructs. Alternatively, the endogenous gene may be inactivated by methylation, whereas the transfected GASCAT plasmid may not be methylated when cotransfected with the neomycin resistance gene. The strongest stimulation ofgastrin promoter activity was elicited by EGF. Stimulation ofCAT activity by EGF was not a result of nonspecific activation of translation because the activity of the 40 GASCAT construct was not stimulated by EGF (Fig.  6A) . If changes in CAT activity were due to effects on translation, then the CAT activity of the 40 GASCAT construct would also be increased, since all GASCAT constructs express the same mRNA. Gastrin promoter activity was also stimulated by TRH, and this promoter stimulation was similarly abolished in the 40 GASCAT. However, the most potent peptide stimulant of antral G cells, GRP, elicited only weak stimulation of gastrin promoter activity. Yet TRH and GRP elicit similar intracellular responses via increased inositol phospholipid turnover and increased intracellular Ca2+ (38) (39) (40) . GH4 cells have fewer GRP (3000) receptors than TRH (130,000) and somatostatin (13,000) receptors (21, 22, 24) , which may explain the difference between TRH and GRP effects on the gastrin promoter in GH cells.
The stimulation of gastrin promoter activity by both EGF and TRH depended on a 40-bp cis-acting DNA fragment lying between -40 and -82 bp upstream of the gastrin promoter. This segment contains DNA sequence motifs shown to bind two known transcription factors, Spl and AP2 (25, 26) . Transcriptional activation by Spl is not known to be inducible, and Spl sites are commonly found in the proximal promoter region of constitutive housekeeping genes (41) . The activity of the AP2 factor, however, is stimulated by cAMP and phorbol esters through the activation of protein kinase A or protein kinase C, respectively (26) . Therefore, TRH could stimulate gastrin promoter activity by increasing AP2 activity, because TRH increases both cAMP-dependent kinase and protein kinase C activities (42, 43) .
The -40-to -82-bp DNA fragment also confers EGF responsiveness to the gastrin promoter and, thus, is the third DNA sequence identified that confers EGF responsiveness to a promoter active in GH4 cells. Previous studies in GH4 cells have defined DNA fragments of 43 and 53 bp, which confer EGF responsiveness to the prolactin and Moloney LTR promoters, respectively (24) . These DNA fragments do not share common sequence motifs, suggesting that EGF stimulation does not activate a common transcription factor as has been shown for many promoters that are stimulated by cAMP (44) . There is no cross competition between the prolactin and Moloney LTR EGF response elements and the nuclear proteins that specifically bind to these sequences (24) .
The different EGF response elements identified in the prolactin, Moloney LTR, and gastrin promoters also all confer responsiveness to phorbol esters (24) . This suggests that EGF responsiveness is linked to the activation of the protein kinase C pathway. However, evidence that EGF increases protein kinase C activity is incomplete. Cells respond to EGF stimulation with a modest and brief increase in diacylglycerol, but activation of protein kinase C has not been documented (45) . Furthermore, EGF stimulation of the gastrin promoter is significantly greater than the response to maximal stimulation with phorbol 12-myristate 13-acetate (3-vs. 2-fold), implying that the EGF response is not simply due to activation of protein kinase C by diacylglycerol (unpublished observations). EGF also increases intracellular calcium (46, 47) , and the stimulation of prolactin gene expression by EGF is markedly reduced when intracellular calcium is depleted (37, 47) . Studies with a mutant EGF receptor also indicate that the transcriptional stimulation and the increase in intracellular calcium are linked (48) . The increase in intracellular calcium induced by EGF may potentiate the activation of protein kinase C, because the activity of this enzyme is stimulated by calcium (49) . Although AP2 activity is stimulated by cAMP and gastrin promoter activity increases 3-fold with cAMP (unpublished results), it is unlikely that EGF-mediated effects on the gastrin promoter occur via cAMP-dependent pathways because EGF does not increase intracellular cAMP (50, 51) . Furthermore, EGF antagonizes the cAMP-dependent effects of thyroid-stimulating hormone of thyroid cells (52) and glucagon on kidney cells (51) .
The present study also shows that the inhibitory peptide somatostatin antagonizes EGF and TRH stimulation of gastrin promoter activity in GH4 cells. This result is interesting because reported effects of somatostatin on gene expression have given conflicting interpretations. Although somatostatin was shown to inhibit growth hormone secretion, no effect on growth hormone gene transcription was seen (53) . This suggests a dissociation between the inhibitory effects of somatostatin on secretion from effects on gene transcription. However, there are differences between these two studies, which make these divergent observations not directly comparable. For Biochemistry: Godley and Brand in the present study GH4 cells were incubated with somatostatin for 24 hr. Prolonged action by somatostatin may have effects on gene transcription not seen after brief exposure.
Somatostatin inhibited gastrin promoter activity stimulated by TRH and EGF but had little effect on basal gastrin promoter activity. This result implies that somatostatin inhibits one or more events in the intracellular signaling pathways activated by TRH and EGF. Somatostatin has well-described inhibitory effects on the activation of adenylate cyclase and on the increase in intracellular calcium elicited by TRH. These are mediated by the inhibitory guanine nucleotide-binding protein (G1) because these two effects are sensitive to pertussis toxin inhibition (54, 55) . Preliminary studies with pertussis toxin-pretreated cells showed a reversal of somatostatin inhibition of EGFstimulated cells, implicating a role for G proteins in modulating gene transcription. Further studies will confirm whether the effects of somatostatin on gene transcription are mediated by the same intracellular mechanisms that inhibit secretion.
